Literature DB >> 16229862

Effect of hypertension on angiotensin-(1-7) levels in rats with different angiotensin-I converting enzyme polymorphism.

María Paz Ocaranza1, Cristián Palomera, Maritza Román, Jorge Bargetto, Sergio Lavandero, Jorge E Jalil.   

Abstract

To determine circulating angiotensin-(1-7) [Ang-(1,7)] levels in rats with different angiotensin converting enzyme (ACE) genotypes and to evaluate the effect of hypertension on levels of this heptapeptide, plasma levels of angiotensin II (Ang II) and Ang-(1-7) were determined by HPLC and radioimmunoassay in (a) normotensive F0 and F2 homozygous Brown Norway (BN; with high ACE) or Lewis (with low ACE) rats and (b) in hypertensive F2 homozygous male rats (Goldblatt model). Genotypes were characterized by PCR and plasma ACE activity measured by fluorimetry. Plasma ACE activity was 2-fold higher (p < 0.05) in homozygous BN compared to homozygous Lewis groups. In the Goldblatt groups, a similar degree of hypertension and left ventricular hypertrophy was observed in rats with both genotypes. Plasma Ang II levels were between 300-400% higher (p < 0.05) in the BN than in the Lewis rats, without increment in the hypertensive animals. Plasma Ang-(1-7) levels were 75-87% lower in the BN rats (p < 0.05) and they were significantly higher (p < 0.05) in the hypertensive rats from both genotypes. Plasma levels of Ang II and Ang-(1-7) levels were inversely correlated in the normotensive rats (r = -0.64; p < 0.001), but not in the hypertensive animals. We conclude that there is an inverse relationship between circulating levels of Ang II and Ang-(1-7) in rats determined by the ACE gene polymorphism. This inverse relation is due to genetically determined higher ACE activity. Besides, plasma levels of Ang-(1-7) increase in renovascular hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16229862     DOI: 10.1016/j.lfs.2005.07.026

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Determination of Angiotensin-(1-7) with HPLC/Fluorescence-Detection.

Authors:  Miriam Russ; Susanne Hauser; Reinhold Wintersteiger; Joachim Greilberger; Michaela Andrä; Astrid Ortner
Journal:  J Fluoresc       Date:  2015-10-09       Impact factor: 2.217

2.  A novel rodent model of pregnancy complications associated with genetically determined angiotensin-converting enzyme (ACE) activity.

Authors:  Eugenia Mata-Greenwood; Arlin B Blood; LeeAnna D Sands; Shannon L Bragg; Daliao Xiao; Lubo Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-01-23       Impact factor: 4.310

3.  Impact of genetic background and aging on mesenteric collateral growth capacity in Fischer 344, Brown Norway, and Fischer 344 x Brown Norway hybrid rats.

Authors:  Kevin M Sheridan; Michael J Ferguson; Matthew R Distasi; Frank A Witzmann; Michael C Dalsing; Steven J Miller; Joseph L Unthank
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-09-28       Impact factor: 4.733

Review 4.  Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease.

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Leanne Groban
Journal:  Clin Sci (Lond)       Date:  2020-10-16       Impact factor: 6.876

5.  Effects of Short-term Renovascular Hypertension and Type 2 Diabetes on Cardiac Functions in Rats.

Authors:  Ali Akbar Nekooeian; Azadeh Khalili; Mohammad Bagher Khosravi
Journal:  Iran J Med Sci       Date:  2014-01

6.  Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium.

Authors:  Sonu Bhaskar; Aarushi Rastogi; Vijay Kumar Chattu; Anil Adisesh; Pravin Thomas; Negman Alvarado; Anis D Riahi; Chakrakodi N Varun; Anupama R Pai; Sarah Barsam; Antony H Walker
Journal:  Front Cardiovasc Med       Date:  2020-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.